Kinnate Biopharma Inc. Annual Return On Equity in % from 2020 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kinnate Biopharma Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2022.
  • Kinnate Biopharma Inc. Return On Equity for the quarter ending December 31, 2022 was -44.7 %, a 74.2% decline year-over-year.
  • Kinnate Biopharma Inc. annual Return On Equity for 2022 was -44.7 %, a 74.2% decline from 2021.
  • Kinnate Biopharma Inc. annual Return On Equity for 2021 was -25.6 %, a 45.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -44.7 -19 -74.2% Jan 1, 2022 Dec 31, 2022
2021 -25.6 +21.2 +45.3% Jan 1, 2021 Dec 31, 2021
2020 -46.9 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.